Left Ventricular Assist Device in Older Adults

Area of Science:

• Cardiology and Medical Engineering
• Advanced heart failure therapies

Background:

• Growing and aging population with limited donor hearts necessitates alternative treatments.
• Left ventricular assist devices (LVADs) are a critical option for end-stage heart failure.

Observation:

• Patient selection for LVADs requires comprehensive assessment of indications, risks, and potential for right ventricular failure.
• Optimal timing for LVAD implantation is a key consideration for successful outcomes.

Findings:

• LVAD implantation carries a 5-10% perioperative mortality risk.
• Common complications include bleeding, thrombosis, stroke, infection, right ventricular failure, and device malfunction.

Implications:

• Evolving LVAD technology necessitates updated risk-prediction models.
• Large-scale, multicenter prospective studies are essential for refining patient selection and reducing complications.
• Continued research will improve long-term LVAD therapy outcomes.